Global Infantile Spasms Therapeutics Market Data Survey Report 2013-2025
SUMMARY
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global Infantile Spasms Therapeutics market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global Infantile Spasms Therapeutics market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
- H. Lundbeck
- Mallinckrodt
- Insys Therapeutics
- Orphelia Pharma
- Valerion Therapeutics
- Catalyst Pharmaceuticals
- Anavex Life Sciences
- Retrophin
- Hospital
- Clinic
- Others
- Oral
- Injection
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 H. Lundbeck
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Mallinckrodt
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Insys Therapeutics
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Orphelia Pharma
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Valerion Therapeutics
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Catalyst Pharmaceuticals
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Anavex Life Sciences
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Retrophin
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Clinic
4.2.1 Overview
4.2.2 Clinic Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET BY TYPE
5.BY ORAL
5.1 Oral
5.1.1 Overview
5.1.2 Oral Market Size and Forecast
5.2 Injection
5.2.1 Overview
5.2.2 Injection Market Size and Forecast
6 PRICE OVERVIEW
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 H. Lundbeck
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Mallinckrodt
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Insys Therapeutics
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Orphelia Pharma
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Valerion Therapeutics
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Catalyst Pharmaceuticals
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Anavex Life Sciences
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Retrophin
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Clinic
4.2.1 Overview
4.2.2 Clinic Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET BY TYPE
5.BY ORAL
5.1 Oral
5.1.1 Overview
5.1.2 Oral Market Size and Forecast
5.2 Injection
5.2.1 Overview
5.2.2 Injection Market Size and Forecast
6 PRICE OVERVIEW
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 CONCLUSION
LIST OF TABLES
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of H. Lundbeck
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mallinckrodt
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Insys Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Orphelia Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Valerion Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Catalyst Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Anavex Life Sciences
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Retrophin
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of H. Lundbeck
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mallinckrodt
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Insys Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Orphelia Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Valerion Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Catalyst Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Anavex Life Sciences
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Retrophin
LIST OF FIGURES
Fig Global Infantile Spasms Therapeutics Market Size and CAGR 2013-2018 (Million USD)
Fig Global Infantile Spasms Therapeutics Market Size and CAGR 2013-2018 (Volume)
Fig Global Infantile Spasms Therapeutics Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Infantile Spasms Therapeutics Market Forecast and CAGR 2019-2025 (Volume)
Fig Hospital Market Size and CAGR 2013-2018 (Million USD)
Fig Hospital Market Size and CAGR 2013-2018 (Volume)
Fig Hospital Market Forecast and CAGR 2019-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2019-2025 (Volume)
Fig Clinic Market Size and CAGR 2013-2018 (Million USD)
Fig Clinic Market Size and CAGR 2013-2018 (Volume)
Fig Clinic Market Forecast and CAGR 2019-2025 (Million USD)
Fig Clinic Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig Oral Market Size and CAGR 2013-2018 (Million USD)
Fig Oral Market Size and CAGR 2013-2018 (Volume)
Fig Oral Market Forecast and CAGR 2019-2025 (Million USD)
Fig Oral Market Forecast and CAGR 2019-2025 (Volume)
Fig Injection Market Size and CAGR 2013-2018 (Million USD)
Fig Injection Market Size and CAGR 2013-2018 (Volume)
Fig Injection Market Forecast and CAGR 2019-2025 (Million USD)
Fig Injection Market Forecast and CAGR 2019-2025 (Volume)
Fig Global Infantile Spasms Therapeutics Market Size and CAGR 2013-2018 (Million USD)
Fig Global Infantile Spasms Therapeutics Market Size and CAGR 2013-2018 (Volume)
Fig Global Infantile Spasms Therapeutics Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Infantile Spasms Therapeutics Market Forecast and CAGR 2019-2025 (Volume)
Fig Hospital Market Size and CAGR 2013-2018 (Million USD)
Fig Hospital Market Size and CAGR 2013-2018 (Volume)
Fig Hospital Market Forecast and CAGR 2019-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2019-2025 (Volume)
Fig Clinic Market Size and CAGR 2013-2018 (Million USD)
Fig Clinic Market Size and CAGR 2013-2018 (Volume)
Fig Clinic Market Forecast and CAGR 2019-2025 (Million USD)
Fig Clinic Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig Oral Market Size and CAGR 2013-2018 (Million USD)
Fig Oral Market Size and CAGR 2013-2018 (Volume)
Fig Oral Market Forecast and CAGR 2019-2025 (Million USD)
Fig Oral Market Forecast and CAGR 2019-2025 (Volume)
Fig Injection Market Size and CAGR 2013-2018 (Million USD)
Fig Injection Market Size and CAGR 2013-2018 (Volume)
Fig Injection Market Forecast and CAGR 2019-2025 (Million USD)
Fig Injection Market Forecast and CAGR 2019-2025 (Volume)
